Illinois Tool Works Q2 revenue beats on segment growth; raises outlook
Reuters2026/07/28 12:10
Overview
US industrial manufacturer's Q2 revenue rose 6.1%, beating analyst expectations
Q2 GAAP EPS grew 10.1% to $2.84, beating analyst expectations
Company raised full-year 2026 revenue and EPS guidance
Outlook
Illinois Tool Works raises 2026 GAAP EPS guidance to $11.35-$11.55, up $0.15
Company raises 2026 organic revenue growth guidance to 3-4%, up 1.5 percentage points
Illinois Tool Works projects 2026 operating margin of 26.5-27.5%
Result Drivers
SEGMENT GROWTH - Double-digit organic growth in Welding and Test Measurement and Electronics segments, with strong performance in Polymers Fluids, drove overall results
MARGIN EXPANSION - Operating margin expanded 40 bps to 26.7% as enterprise initiatives contributed 120 bps
PRICING ACTIONS - Price increases more than offset higher raw material costs, though timing lags modestly diluted margins
Company press release: ID:nGNX77BC94
Key Details
Metric |
Beat/Miss |
Actual |
Consensus Estimate |
Q2 Revenue |
Beat |
$4.30 bln |
$4.19 bln (12 Analysts) |
Q2 EPS |
Beat |
$2.84 |
$2.79 (13 Analysts) |
Q2 Net Income |
|
$815 mln |
|
Q2 Organic Growth |
|
4.50% |
|
Analyst Coverage
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 2 "strong buy" or "buy", 11 "hold" and 4 "sell" or "strong sell"
The average consensus recommendation for the consumer goods conglomerates peer group is "buy."
Wall Street's median 12-month price target for Illinois Tool Works Inc is $278.00, about 2.4% below its July 27 closing price of $284.82
The stock recently traded at 24 times the next 12-month earnings vs. a P/E of 23 three months ago
Reuters Recommended Reads
July 28 - Xylem raises annual profit forecast as AI growth lifts demand for water-treatment equipment
July 28 - Carrier raises annual earnings forecast on air conditioning demand
July 28 - Oshkosh Q2 profit beats on improved pricing
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Analyst: This 2026 XRP Price Prediction Way Well Go Into the History Books
Bitcoin Red Team Claims Blockstream Ignored Warnings Before Hack
Bitcoin's Weirdest Trader Yet? Fly Brain Makes a Profit
Heart Disease, a Historic Strength for Big Pharma, Becomes a Weakness - Heard on the Street -- WSJ